Modeling the cost‐effectiveness and impact on fatal overdose and initiation of buprenorphine–naloxone treatment at syringe service programs-Reference-Cited by-同舟云学术

Modeling the cost‐effectiveness and impact on fatal overdose and initiation of buprenorphine–naloxone treatment at syringe service programs

Published:2022-04-03 Issue:10 Volume:117 Page:2635-2648
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Adams Joëlla W.¹²^ORCID,Savinkina Alexandra¹,Fox Aaron³,Behrends Czarina N.⁴^ORCID,Madushani Rajapaksha W. M. A.¹,Wang Jianing¹,Chatterjee Avik⁵⁶,Walley Alexander Y.⁵⁶,Barocas Joshua A.⁷,Linas Benjamin P.¹⁶

Affiliation:

1. Section of Infectious Diseases Boston Medical Center (BMC) Boston MA USA

2. RTI International, Research Triangle NC USA

3. Montefiore Medical Center and Albert Einstein College of Medicine New York NY USA

4. Department of Population Health Sciences Weill Cornell Medical College New York City NY USA

5. Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center Boston MA USA

6. Boston University School of Medicine Boston MA USA

7. Divisions of General Internal Medicine and Infectious Diseases University of Colorado School of Medicine Aurora CO USA

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

National Institute on Drug Abuse

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/add.15883

Reference49 articles.

1. National Institute on Drug AbuseOverdose Death Rates 2021. Available at:https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates(Accessed March 25 2022).

2. Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder

3. National Health Care for the Homeless Council.Medication‐Assisted Treatment: Buprenorphine in the HCH Community. Nashville TN: National Health Care for the Homeless Council;2016.

4. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population

5. Defining Low-threshold Buprenorphine Treatment

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluation of the effect of needle and syringe programs on skin, soft tissue, and vascular infections in people who inject drugs: a microsimulation modelling approach;Harm Reduction Journal;2024-06-28

2. Innovation in the Delivery of Behavioral Health Services;Annual Review of Public Health;2023-10-23

3. Use of Big Data and Ethical Issues for Populations With Substance Use Disorder;Value in Health;2023-09

4. Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature;Addiction Science & Clinical Practice;2023-06-10

5. A qualitative study: harm reduction and opioid overdose strategies for Black and Latinx opioid overdose survivors;Journal of Social Work Practice in the Addictions;2022-12-01